… cells in atherosclerosis is based … cytokines are attractive targets for developing new preventive
and therapeutic approaches including potential T cell-related therapies for atherosclerosis…

… Cytokines and Igs produced by B cells at these sites are thought to be important regulators
of inflammation in atherosclerosis … cell–derived Igs modulate atherosclerosis, with a focus on …

… cytokine in the atherosclerosis lesions. IL10 delivered by NC was bioactive and reduced the
production of pro-inflammatory cytokine … prospect of nanoparticle based cytokine delivery for …

… cytokines such as during a cytokine storm can lead to organ failure and death. For example,
a consensus is that “cytokine … [ 7, 8 ] Consequently, the levels of cytokines are recognized as …

… the release of cytokines. All of these functions have the potential to affect atherosclerosis by
… the mechanism of B cell activation under atherosclerosis-prone conditions. By summarizing …

… of these proatherogenic cytokines in a group of healthy adults. In this analysis, we also
included other cytokines and peptides that have been implicated in atherosclerosis development …

… On the other hand, in the presence of atherosclerosis, the higher levels of inflammatory
cytokines induce the activation of neutrophils which, in turn, overexpress adhesion molecules …

Atherosclerosis is a chronic progressive disease that involves damage to the intima,
inflammatory cell recruitment and the accumulation of lipids followed by calcification and plaque …

… blood vessels, which often happens at the initiation of atherosclerosis (37). In general,
adhesion molecules include intercellular inflammatory cytokines (ICAM-1), vascular cell molecule (…

… Treg cells express anti-inflammatory cytokines (IL-10 and TGFβ), promote macrophage
efferocytosis, and show a negative correlation with atherosclerosis. T H 2 cells express IL-5 and …